Treatment of patients with malignant pleural effusions due to advanced lung cancer by transfer of autologous LAK cells combined with rIL-2 or rIL-2 alone.
Li
D
D
Heilongjiang Branch, CAMS, Harbin.
Wang
Y
Y
Yao
X
X
Shao
J
J
Chen
Y
Y
Ba
D
D
D000230:Adenocarcinoma / Q000150:complications*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010996:Pleural Effusion / Q000628:therapy*
D007376:Interleukin-2